Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,748 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in Japan.
Taguchi Y, Ebina M, Hashimoto S, Ogura T, Azuma A, Taniguchi H, Kondoh Y, Suga M, Takahashi H, Nakata K, Sugiyama Y, Kudoh S, Nukiwa T; Pirfenidone Clinical Study Group in Japan. Taguchi Y, et al. Among authors: nakata k. Respir Investig. 2015 Nov;53(6):279-87. doi: 10.1016/j.resinv.2015.06.002. Epub 2015 Oct 23. Respir Investig. 2015. PMID: 26521105
The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial.
Taniguchi H, Kondoh Y, Ebina M, Azuma A, Ogura T, Taguchi Y, Suga M, Takahashi H, Nakata K, Sato A, Sugiyama Y, Kudoh S, Nukiwa T; Pirfenidone Clinical Study Group in Japan. Taniguchi H, et al. Among authors: nakata k. Respir Res. 2011 Jul 15;12(1):93. doi: 10.1186/1465-9921-12-93. Respir Res. 2011. PMID: 21756364 Free PMC article. Clinical Trial.
Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment.
Azuma A, Taguchi Y, Ogura T, Ebina M, Taniguchi H, Kondoh Y, Suga M, Takahashi H, Nakata K, Sato A, Kudoh S, Nukiwa T; Pirfenidone Clinical Study Group in Japan. Azuma A, et al. Among authors: nakata k. Respir Res. 2011 Oct 28;12(1):143. doi: 10.1186/1465-9921-12-143. Respir Res. 2011. PMID: 22035508 Free PMC article. Clinical Trial.
Promoter analysis and aberrant expression of the MUC5B gene in diffuse panbronchiolitis.
Kamio K, Matsushita I, Hijikata M, Kobashi Y, Tanaka G, Nakata K, Ishida T, Tokunaga K, Taguchi Y, Homma S, Nakata K, Azuma A, Kudoh S, Keicho N. Kamio K, et al. Among authors: nakata k. Am J Respir Crit Care Med. 2005 May 1;171(9):949-57. doi: 10.1164/rccm.200409-1168OC. Epub 2005 Feb 11. Am J Respir Crit Care Med. 2005. PMID: 15709052
Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis.
Huqun, Izumi S, Miyazawa H, Ishii K, Uchiyama B, Ishida T, Tanaka S, Tazawa R, Fukuyama S, Tanaka T, Nagai Y, Yokote A, Takahashi H, Fukushima T, Kobayashi K, Chiba H, Nagata M, Sakamoto S, Nakata K, Takebayashi Y, Shimizu Y, Kaneko K, Shimizu M, Kanazawa M, Abe S, Inoue Y, Takenoshita S, Yoshimura K, Kudo K, Tachibana T, Nukiwa T, Hagiwara K. Huqun, et al. Among authors: nakata k. Am J Respir Crit Care Med. 2007 Feb 1;175(3):263-8. doi: 10.1164/rccm.200609-1274OC. Epub 2006 Nov 9. Am J Respir Crit Care Med. 2007. PMID: 17095743
[Cyclosporin A treatment of interstitial pneumonia].
Homma S, Kawabata M, Kishi K, Tsuboi E, Narui K, Nakatani T, Matsushita H, Kurosaki A, Nakata K. Homma S, et al. Among authors: nakata k. Nihon Kokyuki Gakkai Zasshi. 2003 Jul;41(7):427-33. Nihon Kokyuki Gakkai Zasshi. 2003. PMID: 12931668 Japanese.
1,748 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page